Prof Murat Emre
MD, DMsc, professor, chair of the Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey.
Professor Emre is President of the Turkish Alzheimer Society, a member of the International Executive Committee of Movement Disorder Society-European Section and member of EFNS Congress Programme Committee. He is on the Editorial Board of Movement Disorders, Practical Neurology and Clinical Neuropharmacology. He is a neurologist with a special interest in Parkinson's disease and Alzheimer's disease.
Contributions to CNSforum by Prof Murat Emre:
24.11.2006
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
26.10.2006
Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
27.09.2006
Dissociating apathy and depression in Parkinson disease
24.08.2006
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study
25.07.2006
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease
23.06.2006
Normalizing motor-related brain activity: subthalamic nucleus stimulation in Parkinson disease
23.05.2006
Randomized controlled trial of intraputaminal glial cell line-derived neurotrophic factor infusion in Parkinson disease
28.04.2006
A randomized, double blind, futility clinical trial of creatine and minocycline in early Parkinson disease
22.03.2006
Visual dysfunction in Parkinson disease without dementia
20.02.2006
Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.
17.01.2006
Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow-up
22.11.2005
Visual hallucinations in the diagnosis of idiopathic Parkinson’s disease: a retrospective autopsy study
23.10.2005
Effects of serotonin 5-HT1A agonist in advanced Parkinson’s disease
21.09.2005
Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel.
22.08.2005
Dietary fatty acids and the risk of Parkinson disease. The Rotterdam study.
26.07.2005
Rasagiline as an adjunct to levodopa in patients with Parkinson’s disease and motor fluctuations (LARGO, Lasting Effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomized, double-blind, parallel group trial.
16.06.2005
Cognitive status correlates with neuropathologic stage in Parkinson disease
20.05.2005
Acute akinesia in Parkinson disease
21.04.2005
Cigarette smoking and Parkinson’s disease: a case-control study in a population characterized by high prevalence of pesticide exposure.
22.03.2005
A randomized, placebo controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations. The PRESTO study
22.02.2005
Levodopa and the progression of Parkinson’s disease